PC158. Comparative Study Between Rivaroxaban and Standard Therapy (Enoxaparin Followed by Acitrom [Vitamin K Antagonist]) for Treatment of Deep Venous Thrombosis

Journal of Vascular Surgery - United States
doi 10.1016/j.jvs.2019.04.372
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness Analysis of Treatment of Venous Thromboembolism With Rivaroxaban Compared With Combined Low Molecular Weight Heparin/Vitamin K Antagonist

Thrombosis Journal
Hematology
2015English

Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data

PLoS ONE
Multidisciplinary
2015English

The Use of Rivaroxaban in Deep Venous Thrombosis Associated With Vena Cava Inferior Agenesis

Turkish Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Strategy for Deep Venous Thrombosis

The Japanese Journal of Rehabilitation Medicine
2009English

Anticoagulants for Deep Venous Thrombosis

Journal of the Royal Society of Medicine
Medicine
2001English

Treatment of Deep Vein Thrombosis With Enoxaparin in Pediatric Cancer Patients Receiving Chemotherapy

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2007English

Treatment of Deep Vein Thrombosis With Enoxaparin in Pediatric Cancer Patients Receiving Chemotherapy.

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

When Deep Venous Thrombosis Fails to Respond to Therapy

Journal of the American Board of Family Medicine
EnvironmentalPublic HealthFamily PracticeOccupational Health
2003English

Updates on Prophylaxis for Deep Venous Thrombosis and Venous Thromboembolism

Medical Research Archives
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy